Research and development of serological diagnosis of gynecological cancer.
| Project/Area Number |
15K15602
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | Hamamatsu University School of Medicine |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
村上 浩雄 浜松医科大学, 医学部附属病院, 助教 (10432212)
柴田 俊章 浜松医科大学, 医学部, 助教 (50529568)
|
|---|
| Project Period (FY) |
2015-04-01 – 2018-03-31
|
| Project Status |
Completed (Fiscal Year 2017)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
|
|---|
| Keywords | バイオマーカー / 血清マーカー / 婦人科学 |
|---|
| Outline of Final Research Achievements |
The molecule which specifically expressed for malignant tumors of the field of gynecology and obstetrics was screened. We carried out close inspection in mind in possibilities of the clinical application continuously. In 2018, we identified the molecule which specifically expressed for gynecologic cancer. The molecule expressed with various tissues of ovarian cancer. After the approval of the Ethical Review Board, we are investigating whether it can be the biomarker.
|
Report
(3 results)
Research Products
(6 results)
